SCHEMBL7974052

SCHEMBL7974052

CN(CC(=O)Nc1ncn(Cc2cccc(Cl)c2)c1C(N)=O)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
YTHDC1 Q96MU7 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.38
UBE2N P61088 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CDK9 P50750 1/20 0.38
ADRA1D P25100 1/20 0.37
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
HTR2C P28335 1/20 0.36
SLC6A4 P31645 1/20 0.36
POLB P06746 1/20 0.35
KCNQ2 O43526 1/20 0.35
PLA2G1B P04054 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CNR2 P34972 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7992102 0.91 HTR2C (0.41) KDM4EL3MBTL1HTR2CSLC6A4
SCHEMBL7974433 0.89 TP53 (0.40) YTHDC1ADRA1DMAPTTP53RXFP1
SCHEMBL7987693 0.87 TDP1 (0.34) KDM4EL3MBTL1HTTSMN1; SMN2MAPT
SCHEMBL7984765 0.86 GRM2 (0.36) KDM4ECDK9MAPTCNR2
SCHEMBL7988995 0.86 NR1H4 (0.38)
SCHEMBL7991771 0.83 KMT2A (0.39) KDM4EMAPTHTR2CSLC6A4
SCHEMBL7974264 0.82 HTR2C (0.40) HTR2CSLC6A4
SCHEMBL7989013 0.81 TP53 (0.38) KDM4EL3MBTL1MAPTTP53RXFP1
SCHEMBL7974162 0.81 KDM4E (0.52) KDM4EYTHDC1L3MBTL1GLAHTT
SCHEMBL7987776 0.81 KDM4E (0.41) KDM4EHTR2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed